img

Global Genetically Modified Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Genetically Modified Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Drugs made by genetically modified means are also called "biological drugs"
Genetically Modified Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Genetically Modified Drug market is projected to reach US$ 3481 million in 2029, increasing from US$ 2314 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2024, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Genetically Modified Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


LFB Biotechnologies SA
Pharming Group NV
Pfizer
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Amgen
F. Hoffmann-La Roche
Sanofi
Novartis
Eli Lilly
Takeda
Baxter
GlaxoSmithKline
Segment by Type
Transgenic Animal
Transgenic Plant

Segment by Application


Hospital
Clinic

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Genetically Modified Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Genetically Modified Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Genetically Modified Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Genetically Modified Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Genetically Modified Drug introduction, etc. Genetically Modified Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Genetically Modified Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Genetically Modified Drug Market Overview
1.1 Genetically Modified Drug Product Overview
1.2 Genetically Modified Drug Market Segment by Type
1.2.1 Transgenic Animal
1.2.2 Transgenic Plant
1.3 Global Genetically Modified Drug Market Size by Type
1.3.1 Global Genetically Modified Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Genetically Modified Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Genetically Modified Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Genetically Modified Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Genetically Modified Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Genetically Modified Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Genetically Modified Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Genetically Modified Drug Sales Breakdown by Type (2018-2024)
2 Global Genetically Modified Drug Market Competition by Company
2.1 Global Top Players by Genetically Modified Drug Sales (2018-2024)
2.2 Global Top Players by Genetically Modified Drug Revenue (2018-2024)
2.3 Global Top Players by Genetically Modified Drug Price (2018-2024)
2.4 Global Top Manufacturers Genetically Modified Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Genetically Modified Drug Market Competitive Situation and Trends
2.5.1 Genetically Modified Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Genetically Modified Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genetically Modified Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Genetically Modified Drug Market
2.8 Key Manufacturers Genetically Modified Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Genetically Modified Drug Status and Outlook by Region
3.1 Global Genetically Modified Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Genetically Modified Drug Historic Market Size by Region
3.2.1 Global Genetically Modified Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Genetically Modified Drug Sales in Value by Region (2018-2024)
3.2.3 Global Genetically Modified Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Genetically Modified Drug Forecasted Market Size by Region
3.3.1 Global Genetically Modified Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Genetically Modified Drug Sales in Value by Region (2024-2029)
3.3.3 Global Genetically Modified Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Genetically Modified Drug by Application
4.1 Genetically Modified Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Genetically Modified Drug Market Size by Application
4.2.1 Global Genetically Modified Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Genetically Modified Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Genetically Modified Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Genetically Modified Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Genetically Modified Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Genetically Modified Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Genetically Modified Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Genetically Modified Drug Sales Breakdown by Application (2018-2024)
5 North America Genetically Modified Drug by Country
5.1 North America Genetically Modified Drug Historic Market Size by Country
5.1.1 North America Genetically Modified Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Genetically Modified Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Genetically Modified Drug Sales in Value by Country (2018-2024)
5.2 North America Genetically Modified Drug Forecasted Market Size by Country
5.2.1 North America Genetically Modified Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Genetically Modified Drug Sales in Value by Country (2024-2029)
6 Europe Genetically Modified Drug by Country
6.1 Europe Genetically Modified Drug Historic Market Size by Country
6.1.1 Europe Genetically Modified Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Genetically Modified Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Genetically Modified Drug Sales in Value by Country (2018-2024)
6.2 Europe Genetically Modified Drug Forecasted Market Size by Country
6.2.1 Europe Genetically Modified Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Genetically Modified Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Genetically Modified Drug by Region
7.1 Asia-Pacific Genetically Modified Drug Historic Market Size by Region
7.1.1 Asia-Pacific Genetically Modified Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Genetically Modified Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Genetically Modified Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Genetically Modified Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Genetically Modified Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Genetically Modified Drug Sales in Value by Region (2024-2029)
8 Latin America Genetically Modified Drug by Country
8.1 Latin America Genetically Modified Drug Historic Market Size by Country
8.1.1 Latin America Genetically Modified Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Genetically Modified Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Genetically Modified Drug Sales in Value by Country (2018-2024)
8.2 Latin America Genetically Modified Drug Forecasted Market Size by Country
8.2.1 Latin America Genetically Modified Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Genetically Modified Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Genetically Modified Drug by Country
9.1 Middle East and Africa Genetically Modified Drug Historic Market Size by Country
9.1.1 Middle East and Africa Genetically Modified Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Genetically Modified Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Genetically Modified Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Genetically Modified Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Genetically Modified Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Genetically Modified Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 LFB Biotechnologies SA
10.1.1 LFB Biotechnologies SA Company Information
10.1.2 LFB Biotechnologies SA Introduction and Business Overview
10.1.3 LFB Biotechnologies SA Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 LFB Biotechnologies SA Genetically Modified Drug Products Offered
10.1.5 LFB Biotechnologies SA Recent Development
10.2 Pharming Group NV
10.2.1 Pharming Group NV Company Information
10.2.2 Pharming Group NV Introduction and Business Overview
10.2.3 Pharming Group NV Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Pharming Group NV Genetically Modified Drug Products Offered
10.2.5 Pharming Group NV Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Pfizer Genetically Modified Drug Products Offered
10.3.5 Pfizer Recent Development
10.4 Roche
10.4.1 Roche Company Information
10.4.2 Roche Introduction and Business Overview
10.4.3 Roche Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Roche Genetically Modified Drug Products Offered
10.4.5 Roche Recent Development
10.5 Abbott Laboratories
10.5.1 Abbott Laboratories Company Information
10.5.2 Abbott Laboratories Introduction and Business Overview
10.5.3 Abbott Laboratories Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Abbott Laboratories Genetically Modified Drug Products Offered
10.5.5 Abbott Laboratories Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Information
10.6.2 Johnson & Johnson Introduction and Business Overview
10.6.3 Johnson & Johnson Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Johnson & Johnson Genetically Modified Drug Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 Merck & Co.
10.7.1 Merck & Co. Company Information
10.7.2 Merck & Co. Introduction and Business Overview
10.7.3 Merck & Co. Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Merck & Co. Genetically Modified Drug Products Offered
10.7.5 Merck & Co. Recent Development
10.8 Amgen
10.8.1 Amgen Company Information
10.8.2 Amgen Introduction and Business Overview
10.8.3 Amgen Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Amgen Genetically Modified Drug Products Offered
10.8.5 Amgen Recent Development
10.9 F. Hoffmann-La Roche
10.9.1 F. Hoffmann-La Roche Company Information
10.9.2 F. Hoffmann-La Roche Introduction and Business Overview
10.9.3 F. Hoffmann-La Roche Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 F. Hoffmann-La Roche Genetically Modified Drug Products Offered
10.9.5 F. Hoffmann-La Roche Recent Development
10.10 Sanofi
10.10.1 Sanofi Company Information
10.10.2 Sanofi Introduction and Business Overview
10.10.3 Sanofi Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Sanofi Genetically Modified Drug Products Offered
10.10.5 Sanofi Recent Development
10.11 Novartis
10.11.1 Novartis Company Information
10.11.2 Novartis Introduction and Business Overview
10.11.3 Novartis Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Novartis Genetically Modified Drug Products Offered
10.11.5 Novartis Recent Development
10.12 Eli Lilly
10.12.1 Eli Lilly Company Information
10.12.2 Eli Lilly Introduction and Business Overview
10.12.3 Eli Lilly Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Eli Lilly Genetically Modified Drug Products Offered
10.12.5 Eli Lilly Recent Development
10.13 Takeda
10.13.1 Takeda Company Information
10.13.2 Takeda Introduction and Business Overview
10.13.3 Takeda Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Takeda Genetically Modified Drug Products Offered
10.13.5 Takeda Recent Development
10.14 Baxter
10.14.1 Baxter Company Information
10.14.2 Baxter Introduction and Business Overview
10.14.3 Baxter Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Baxter Genetically Modified Drug Products Offered
10.14.5 Baxter Recent Development
10.15 GlaxoSmithKline
10.15.1 GlaxoSmithKline Company Information
10.15.2 GlaxoSmithKline Introduction and Business Overview
10.15.3 GlaxoSmithKline Genetically Modified Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 GlaxoSmithKline Genetically Modified Drug Products Offered
10.15.5 GlaxoSmithKline Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Genetically Modified Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Genetically Modified Drug Industrial Chain Analysis
11.4 Genetically Modified Drug Market Dynamics
11.4.1 Genetically Modified Drug Industry Trends
11.4.2 Genetically Modified Drug Market Drivers
11.4.3 Genetically Modified Drug Market Challenges
11.4.4 Genetically Modified Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Genetically Modified Drug Distributors
12.3 Genetically Modified Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Transgenic Animal
Table 2. Major Company of Transgenic Plant
Table 3. Global Genetically Modified Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Genetically Modified Drug Sales by Type (2018-2024) & (K Units)
Table 5. Global Genetically Modified Drug Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Genetically Modified Drug Sales by Type (2018-2024) & (US& Million)
Table 7. Global Genetically Modified Drug Market Share in Value by Type (2018-2024)
Table 8. Global Genetically Modified Drug Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Genetically Modified Drug Sales by Type (2024-2029) & (K Units)
Table 10. Global Genetically Modified Drug Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Genetically Modified Drug Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Genetically Modified Drug Sales Market Share in Value by Type (2024-2029)
Table 13. Global Genetically Modified Drug Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Genetically Modified Drug Sales by Type (2018-2024) & (K Units)
Table 15. North America Genetically Modified Drug Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Genetically Modified Drug Sales (K Units) by Type (2018-2024)
Table 17. Europe Genetically Modified Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Genetically Modified Drug Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Genetically Modified Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Genetically Modified Drug Sales (K Units) by Type (2018-2024)
Table 21. Latin America Genetically Modified Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Genetically Modified Drug Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Genetically Modified Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Genetically Modified Drug Sales by Company (2018-2024) & (K Units)
Table 25. Global Genetically Modified Drug Sales Share by Company (2018-2024)
Table 26. Global Genetically Modified Drug Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Genetically Modified Drug Revenue Share by Company (2018-2024)
Table 28. Global Market Genetically Modified Drug Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Genetically Modified Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Genetically Modified Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genetically Modified Drug as of 2022)
Table 32. Date of Key Manufacturers Enter into Genetically Modified Drug Market
Table 33. Key Manufacturers Genetically Modified Drug Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Genetically Modified Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Genetically Modified Drug Sales by Region (2018-2024) & (K Units)
Table 37. Global Genetically Modified Drug Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Genetically Modified Drug Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Genetically Modified Drug Sales Market Share in Value by Region (2018-2024)
Table 40. Global Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Genetically Modified Drug Sales by Region (2024-2029) & (K Units)
Table 42. Global Genetically Modified Drug Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Genetically Modified Drug Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Genetically Modified Drug Sales Market Share in Value by Region (2024-2029)
Table 45. Global Genetically Modified Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Genetically Modified Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Genetically Modified Drug Sales by Application (2018-2024) & (K Units)
Table 48. Global Genetically Modified Drug Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Genetically Modified Drug Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Genetically Modified Drug Sales Market Share in Value by Application (2018-2024)
Table 51. Global Genetically Modified Drug Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Genetically Modified Drug Sales by Application (2024-2029) & (K Units)
Table 53. Global Genetically Modified Drug Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Genetically Modified Drug Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Genetically Modified Drug Sales Market Share in Value by Application (2024-2029)
Table 56. Global Genetically Modified Drug Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Genetically Modified Drug Sales by Application (2018-2024) (K Units)
Table 58. North America Genetically Modified Drug Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Genetically Modified Drug Sales by Application (2018-2024) (K Units)
Table 60. Europe Genetically Modified Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Genetically Modified Drug Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Genetically Modified Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Genetically Modified Drug Sales by Application (2018-2024) (K Units)
Table 64. Latin America Genetically Modified Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Genetically Modified Drug Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Genetically Modified Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Genetically Modified Drug Sales by Country (2018-2024) & (K Units)
Table 68. North America Genetically Modified Drug Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Genetically Modified Drug Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Genetically Modified Drug Sales Market Share in Value by Country (2018-2024)
Table 71. North America Genetically Modified Drug Sales by Country (2024-2029) & (K Units)
Table 72. North America Genetically Modified Drug Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Genetically Modified Drug Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Genetically Modified Drug Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Genetically Modified Drug Sales by Country (2018-2024) & (K Units)
Table 76. Europe Genetically Modified Drug Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Genetically Modified Drug Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Genetically Modified Drug Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Genetically Modified Drug Sales by Country (2024-2029) & (K Units)
Table 80. Europe Genetically Modified Drug Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Genetically Modified Drug Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Genetically Modified Drug Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Genetically Modified Drug Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Genetically Modified Drug Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Genetically Modified Drug Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Genetically Modified Drug Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Genetically Modified Drug Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Genetically Modified Drug Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Genetically Modified Drug Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Genetically Modified Drug Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Genetically Modified Drug Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Genetically Modified Drug Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Genetically Modified Drug Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Genetically Modified Drug Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Genetically Modified Drug Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Genetically Modified Drug Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Genetically Modified Drug Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Genetically Modified Drug Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Genetically Modified Drug Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Genetically Modified Drug Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Genetically Modified Drug Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Genetically Modified Drug Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Genetically Modified Drug Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Genetically Modified Drug Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Genetically Modified Drug Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Genetically Modified Drug Sales Market Share in Value by Country (2024-2029)
Table 107. LFB Biotechnologies SA Company Information
Table 108. LFB Biotechnologies SA Introduction and Business Overview
Table 109. LFB Biotechnologies SA Genetically Modified Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. LFB Biotechnologies SA Genetically Modified Drug Product
Table 111. LFB Biotechnologies SA Recent Development
Table 112. Pharming Group NV Company Information
Table 113. Pharming Group NV Introduction and Business Overview
Table 114. Pharming Group NV Genetically Modified Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Pharming Group NV Genetically Modified Drug Product
Table 116. Pharming Group NV Recent Development
Table 117. Pfizer Company Information
Table 118. Pfizer Introduction and Business Overview
Table 119. Pfizer Genetically Modified Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Pfizer Genetically Modified Drug Product
Table 121. Pfizer Recent Development
Table 122. Roche Company Information
Table 123. Roche Introduction and Business Overview
Table 124. Roche Genetically Modified Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Roche Genetically Modified Drug Product
Table 126. Roche Recent Development
Table 127. Abbott Laboratories Company Information
Table 128. Abbott Laboratories Introduction and Business Overview
Table 129. Abbott Laboratories Genetically Modified Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Abbott Laboratories Genetically Modified Drug Product
Table 131. Abbott Laboratories Recent Development
Table 132. Johnson & Johnson Company Information
Table 133. Johnson & Johnson Introduction and Business Overview
Table 134. Johnson & Johnson Genetically Modified Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Johnson & Johnson Genetically Modified Drug Product
Table 136. Johnson & Johnson Recent Development
Table 137. Merck & Co. Company Information
Table 138. Merck & Co. Introduction and Business Overview
Table 139. Merck & Co. Genetically Modified Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Merck & Co. Genetically Modified Drug Product
Table 141. Merck & Co. Recent Development
Table 142. Amgen Company Information
Table 143. Amgen Introduction and Business Overview
Table 144. Amgen Genetically Modified Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Amgen Genetically Modified Drug Product
Table 146. Amgen Recent Development
Table 147. F. Hoffmann-La Roche Company Information
Table 148. F. Hoffmann-La Roche Introduction and Business Overview
Table 149. F. Hoffmann-La Roche Genetically Modified Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. F. Hoffmann-La Roche Genetically Modified Drug Product
Table 151. F. Hoffmann-La Roche Recent Development
Table 152. Sanofi Company Information
Table 153. Sanofi Introduction and Business Overview
Table 154. Sanofi Genetically Modified Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Sanofi Genetically Modified Drug Product
Table 156. Sanofi Recent Development
Table 157. Novartis Company Information
Table 158. Novartis Introduction and Business Overview
Table 159. Novartis Genetically Modified Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Novartis Genetically Modified Drug Product
Table 161. Novartis Recent Development
Table 162. Eli Lilly Company Information
Table 163. Eli Lilly Introduction and Business Overview
Table 164. Eli Lilly Genetically Modified Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Eli Lilly Genetically Modified Drug Product
Table 166. Eli Lilly Recent Development
Table 167. Takeda Company Information
Table 168. Takeda Introduction and Business Overview
Table 169. Takeda Genetically Modified Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Takeda Genetically Modified Drug Product
Table 171. Takeda Recent Development
Table 172. Baxter Company Information
Table 173. Baxter Introduction and Business Overview
Table 174. Baxter Genetically Modified Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Baxter Genetically Modified Drug Product
Table 176. Baxter Recent Development
Table 177. GlaxoSmithKline Company Information
Table 178. GlaxoSmithKline Introduction and Business Overview
Table 179. GlaxoSmithKline Genetically Modified Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. GlaxoSmithKline Genetically Modified Drug Product
Table 181. GlaxoSmithKline Recent Development
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Genetically Modified Drug Market Trends
Table 185. Genetically Modified Drug Market Drivers
Table 186. Genetically Modified Drug Market Challenges
Table 187. Genetically Modified Drug Market Restraints
Table 188. Genetically Modified Drug Distributors List
Table 189. Genetically Modified Drug Downstream Customers
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Genetically Modified Drug Product Picture
Figure 2. Global Genetically Modified Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Genetically Modified Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Genetically Modified Drug Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Transgenic Animal
Figure 6. Global Transgenic Animal Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Transgenic Plant
Figure 8. Global Transgenic Plant Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Genetically Modified Drug Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Genetically Modified Drug Sales Market Share by Type in 2022 & 2029
Figure 11. North America Genetically Modified Drug Sales Market Share in Volume by Type in 2022
Figure 12. North America Genetically Modified Drug Sales Market Share in Value by Type in 2022
Figure 13. Europe Genetically Modified Drug Sales Market Share in Volume by Type in 2022
Figure 14. Europe Genetically Modified Drug Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Genetically Modified Drug Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Genetically Modified Drug Sales Market Share in Value by Type in 2022
Figure 17. Latin America Genetically Modified Drug Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Genetically Modified Drug Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Genetically Modified Drug Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Genetically Modified Drug Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Genetically Modified Drug Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Genetically Modified Drug Revenue in 2022
Figure 23. Genetically Modified Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Clinic
Figure 27. Global Clinic Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Global Genetically Modified Drug Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Genetically Modified Drug Sales Market Share by Application in 2022 & 2029
Figure 30. North America Genetically Modified Drug Sales Market Share in Volume by Application in 2022
Figure 31. North America Genetically Modified Drug Sales Market Share in Value by Application in 2022
Figure 32. Europe Genetically Modified Drug Sales Market Share in Volume by Application in 2022
Figure 33. Europe Genetically Modified Drug Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Genetically Modified Drug Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Genetically Modified Drug Sales Market Share in Value by Application in 2022
Figure 36. Latin America Genetically Modified Drug Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Genetically Modified Drug Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Genetically Modified Drug Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Genetically Modified Drug Manufacturing Cost Structure
Figure 41. Genetically Modified Drug Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries